Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000947871-25-000659
Filing Date
2025-07-10
Accepted
2025-07-10 09:25:40
Documents
1
Effectiveness Date
2025-07-10
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7981
  Complete submission text file 0000947871-25-000659.txt   9487
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR New York NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR New York NY 10022 212-739-6400
OrbiMed Partners, Ltd. (Filer) CIK: 0001459984 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-129096 | Film No.: 251114989